RNU6-586P

Across TCGA pan-cancer cohorts, RNU6-586P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-586P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-586P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-586P expression acts as an unfavorable survival marker.

KIRP, STAD, and LUAD are the cancer types where RNU6-586P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	81	view →
STAD	OS	Tertile	II,III,IV	0.454	0.722	.021	18	view →
LUAD	OS	Tertile	All	0.310	0.834	.002	18	view →
ESCA	OS	Tertile	All	0.511	0.719	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-586P–KIRP (OS)

Open the KIRP breakdown →